R P Radermecker

Summary

Country: Belgium

Publications

  1. doi request reprint Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, CHU Liege, University of Liege, Liege, Belgium
    Diabetes Metab 39:258-62. 2013
  2. doi request reprint Continuous glucose monitoring reduces both hypoglycaemia and HbA1c in hypoglycaemia-prone type 1 diabetic patients treated with a portable pump
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, CHU de Liege, University of Liege, CHU Sart Tilman, Batiment B35, 4000 Liege, Belgium
    Diabetes Metab 36:409-13. 2010
  3. doi request reprint Management of blood glucose in patients with stroke
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart Tilman, University of Liege, Liege, Belgium
    Diabetes Metab 36:S94-9. 2010
  4. doi request reprint Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liege, University of Liege, Liege, Belgium
    Diabetes Metab Res Rev 25:491-501. 2009
  5. ncbi request reprint [Hereditary hemochromatosis and diabetes mellitus: diagnostic approach and clinical evolution]
    V Thielen
    Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman, Liege
    Rev Med Liege 60:448-54. 2005
  6. ncbi request reprint [Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials]
    R P Radermecker
    CHU Sart Tilman, Liege
    Rev Med Liege 63:511-8. 2008
  7. ncbi request reprint [Risk of hypoglycaemia: therapeutical implications]
    R P Radermecker
    Service de Diabetologie, Nutrition et Maladies Metaboliques, CHU Sart Tilman, 4000 Liege, Belgique
    Rev Med Liege 60:461-5. 2005
  8. ncbi request reprint [Effects of intensive insulin therapy after an acute myocardial infarction in patients with type 2 diabetes: results of the DIGAMI-2 trial]
    A J Scheen
    Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman, Liege
    Rev Med Liege 59:534-9. 2004
  9. ncbi request reprint [Insulin detemir (Levemir)]
    A J Scheen
    Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman, Liege
    Rev Med Liege 60:814-9. 2005
  10. ncbi request reprint Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart Tilman, University of Liege, B 4000 Liege, Belgium
    Diabetes Metab Res Rev 23:348-55. 2007

Collaborators

Detail Information

Publications27

  1. doi request reprint Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, CHU Liege, University of Liege, Liege, Belgium
    Diabetes Metab 39:258-62. 2013
    ..For this reason, this study assessed whether such a goal could be reached with a subcutaneous 'needle-type' enzymatic sensor...
  2. doi request reprint Continuous glucose monitoring reduces both hypoglycaemia and HbA1c in hypoglycaemia-prone type 1 diabetic patients treated with a portable pump
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, CHU de Liege, University of Liege, CHU Sart Tilman, Batiment B35, 4000 Liege, Belgium
    Diabetes Metab 36:409-13. 2010
    ....
  3. doi request reprint Management of blood glucose in patients with stroke
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart Tilman, University of Liege, Liege, Belgium
    Diabetes Metab 36:S94-9. 2010
    ....
  4. doi request reprint Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liege, University of Liege, Liege, Belgium
    Diabetes Metab Res Rev 25:491-501. 2009
    ....
  5. ncbi request reprint [Hereditary hemochromatosis and diabetes mellitus: diagnostic approach and clinical evolution]
    V Thielen
    Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman, Liege
    Rev Med Liege 60:448-54. 2005
    ..If diagnosis occurs later, when the patient already needs insulin therapy, diabetes will not be improved by phlebotomy anymore...
  6. ncbi request reprint [Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials]
    R P Radermecker
    CHU Sart Tilman, Liege
    Rev Med Liege 63:511-8. 2008
    ..The best way to protect type 2 diabetic patients against coronary and cerebrovascular disease is to target all cardiovascular risk factors...
  7. ncbi request reprint [Risk of hypoglycaemia: therapeutical implications]
    R P Radermecker
    Service de Diabetologie, Nutrition et Maladies Metaboliques, CHU Sart Tilman, 4000 Liege, Belgique
    Rev Med Liege 60:461-5. 2005
    ..The present paper briefly describes some clinical situations increasing the risk of hypoglycaemia in diabetic patients treated with insulin or insulin secreting agents, emphasizing upon important therapeutic implications...
  8. ncbi request reprint [Effects of intensive insulin therapy after an acute myocardial infarction in patients with type 2 diabetes: results of the DIGAMI-2 trial]
    A J Scheen
    Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman, Liege
    Rev Med Liege 59:534-9. 2004
    ....
  9. ncbi request reprint [Insulin detemir (Levemir)]
    A J Scheen
    Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman, Liege
    Rev Med Liege 60:814-9. 2005
    ....
  10. ncbi request reprint Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart Tilman, University of Liege, B 4000 Liege, Belgium
    Diabetes Metab Res Rev 23:348-55. 2007
    ..Finally, data on antigenicity and immunogenicity of long-acting insulin analogues (glargine, detemir), which may mimic the basal insulin delivery with CSII, remain scarce at present...
  11. ncbi request reprint [Prevention of hypoglycemia in patients with type 1 diabetes]
    R P Radermecker
    Service de Diabetologie, Nutrition et Maladies Metaboliques, CHU Sart Tilman, Liege
    Rev Med Liege 58:361-8. 2003
    ..There is no doubt that patient's education plays a crucial role in such a strategy that aims at preventing severe hypoglycaemia in type 1 diabetic individuals...
  12. ncbi request reprint [Inhaled insulin, new perspective for insulin therapy]
    R P Radermecker
    Service de Diabetologie, Nutrition et Maladies Metaboliques, CHU Sart Tilman, 4000 Liege, Belgique
    Rev Med Liege 60:355-60. 2005
    ..Nevertheless, inhaled insulin is an attractive topic in which most important pharmaceutical companies are currently involved...
  13. ncbi request reprint [Hypoglycaemic coma, a feared paroxysmal phenomenon in type 1 diabetic patient]
    R P Radermecker
    Service de Diabetologie, Nutrition et Maladies Metaboliques, CHU Sart Tilman, Liege
    Rev Med Liege 59:265-9. 2004
    ..These elements should help to better understand why a hypoglycaemic coma may suddenly occur in a diabetic patient. Some advices will also be given to reduce the risk of such a paroxysmal complication in patients with type 1 diabetes...
  14. doi request reprint Continuous glucose monitoring as a tool to identify hyperglycaemia in non-diabetic patients with acute coronary syndromes
    R P Radermecker
    Endocrinology Department, CHU Montpellier, Universite Montpellier, Montpellier, France
    Diabet Med 26:167-70. 2009
    ..To explore the occurrence and the distribution of glucose excursions > 7.8 mmol/l by continuous glucose monitoring (CGM) in non-diabetic patients admitted with acute coronary syndrome (ACS)...
  15. ncbi request reprint [Biphasic insulin aspart (NovoMix 50)]
    R P Radermecker
    Universite de Liege, Service de Diabetologie, Nutrition et Maladies métaboliques et Unité de Pharmacologie clinique, Departement de Medecine, CHU de Liege, Belgique
    Rev Med Liege 63:688-92. 2008
    ....
  16. ncbi request reprint [Role of insulin secretagogues in the treatment of type 2 diabetes]
    R P Radermecker
    Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman
    Rev Med Liege 60:402-8. 2005
    ..The metabolic effects of glucagon-like peptide-1 (GLP-1) appear very promising, and can be either reproduced by long-acting GLP-1 analogues, or enhanced by inhibitors of dipeptidylpeptidase-IV, an enzyme that destroys GLP-1...
  17. ncbi request reprint [Distinction between good synthesizer and good absorber patients to optimize cholesterol-lowering therapy]
    R P Radermecker
    Université de Liège Service de diabétologie, Nutrition et Maladies Metaboliques, CHU SartTilman, B 4000 Liege I
    Rev Med Suisse 2:1910-5. 2006
    ..They may benefit of an adjunct therapy with phytostanols or ezetimibe, both being capable to reduce plasma concentrations of cholesterol and of phytosterols...
  18. ncbi request reprint [Continuous subcutaneous insulin infusion with portable pumps]
    R P Radermecker
    Universite de Liege, Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman
    Rev Med Liege 60:329-34. 2005
    ..The present paper describes recommendations, advantages and limits as well as cost of CSII with portable pumps in type 1 diabetic patients...
  19. ncbi request reprint [Optimizing the managment of patients with diabetes mellitus: selected clinical trials from the 2004 Congress of the American Diabetes Association]
    A J Scheen
    Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman, Liege
    Rev Med Liege 59:407-12. 2004
    ..The main results and conclusions of these trials are briefly presented as they open new perspectives in the management of patients with type 1 or type 2 diabetes mellitus...
  20. ncbi request reprint [Drug of the month. Ezetimibe/simvastatin tablet (Inegy)]
    A J Scheen
    Universite de Liege, Departement de Medecine, CHU Sart Tilman, Liege, Belgique
    Rev Med Liege 62:585-90. 2007
    ..Ongoing trials aim at proving the efficacy of such a fixed combination in reducing cardiovascular morbidity and mortality...
  21. ncbi request reprint [Field, a randomized clinical trial of cardiovascular prevention with fenofibrate in type 2 diabetes]
    R P Radermecker
    Departement de Medecine, CHU Sart Tilman, 4000 Liege
    Rev Med Liege 60:957-61. 2005
    ..More surprisingly, fenofibrate exerted a favourable effect on microangiopathy complications, with less albuminuria progression and less retinopathy needing laser treatment (tertiary endpoints)...
  22. ncbi request reprint [Effects of glimepiride (Amarylle) in type 2 diabetic patients: results of the Belgian study RECORD in general medicine]
    R P Radermecker
    Service de Diabetologie, Nutrition et Maladies Metaboliques, CHU Sart Tilman, Liege
    Rev Med Liege 61:423-9. 2006
    ..The value of such a study is to provide valuable information about glimepiride use in real life, a condition that may differ from strict follow-up imposed in randomised controlled clinical trials...
  23. ncbi request reprint [How I explore...glycemic kinetics by continuous glucose monitoring]
    R P Radermecker
    Service de Diabetologie, Nutrition et Maladies Metaboliques, CHU Sart Tilman, Liege
    Rev Med Liege 58:164-7. 2003
    ....
  24. ncbi request reprint Estimation of GFR by different creatinine- and cystatin-C-based equations in anorexia nervosa
    P Delanaye
    Department of Nephrology Dialysis, University of Liege, CHU Sart Tilman, Liege, Belgium
    Clin Nephrol 71:482-91. 2009
    ..Glomerular filtration rate (GFR) is overestimated when estimated by the creatinine-based equations. We have studied the accuracy and precision of cystatin C-based equations...
  25. ncbi request reprint [Statin for the brain: update in 2008]
    A J Scheen
    Service de Diabetologie, Nutrition et Maladies métaboliques et Unité de Pharmacologie clinique, CHU Sart Tilman, Liege, Belgique
    Rev Med Liege 63:287-92. 2008
    ..Several ongoing trials should confirm or not confirm this new potential indication of statins in a near future...
  26. doi request reprint Vitamin D and type 2 diabetes mellitus: where do we stand?
    E Cavalier
    Department of Clinical Chemistry, University of Liege, CHU Sart Tilman, 4000 Liege, Belgium
    Diabetes Metab 37:265-72. 2011
    ....
  27. ncbi request reprint [Renal SGLT2 inhibitors, new agents for the management of type 2 diabetes]
    A J Scheen
    Service de Diabetologie, Nutrition et Maladies Metaboliques, Departement de Medecine, CHU Sart Tilman, Liege, Belgique
    Rev Med Suisse 7:1621-4, 1626-9. 2011
    ..Dapagliflozin should be the first medication of this new pharmacological class to be commercialized for the management of type 2 diabetes...